Dutasteride vs. finasteride: why one outperforms the other genetically
Clinical Summary & Executive TakeawayFast Read
Evidence Grade
FDA Approved / Phase 3 International Clinical Data
Target Pathway
Dual Type 1 and Type 2 5 Alpha Reductase Inhibition (>90% serum, >50% scalp DHT suppression)
Safety & Tolerance Note:
Higher systemic DHT suppression than finasteride; monitor for hormonal adverse events.
Practical Patient Verdict:
Clinically superior to finasteride in scalp hair count, particularly when finasteride has plateaued. Requires physician prescription and baseline monitoring.
For men experiencing hair loss, the choice between dutasteride and finasteride has long been a topic of debate, with dutasteride emerging as the more potent option due to its ability to inhibit both types of 5-alpha-reductase enzymes. As researchers like Dr. Vera Price continue to understand the genetic underpinnings of these treatments, it becomes increasingly clear that the difference in efficacy is not just a matter of degree, but of genetic specificity.
Sign in to like, save, or comment.
References & Clinical Data
- Prostaglandin D2 inhibits hair growth and is elevated in bald scalp , Garza LA, et al. (Science Translational Medicine, 2012)
- JAK inhibitors in the treatment of alopecia areata , Craiglow BG, King BA (Journal of Investigative Dermatology, 2015)
- Androgenetic alopecia: pathogenesis and potential for therapy , Blume-Peytavi U, et al. (British Journal of Dermatology, 2011)
- Platelet-rich plasma for androgenetic alopecia: a review , Giordano S, et al. (International Journal of Molecular Sciences, 2023)